Kawsar Talaat, MD
Johns Hopkins Bloomberg School of Public Health
9
9
8
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Matthew J Memoli, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Shared therapeutic areas:
Worked with same sponsors:
Nadine Rouphael, MD
Emory University
Shared therapeutic areas:
Worked with same sponsors:
Veryl Hodges, DO
Clopton Clinic
Shared therapeutic areas:
Shaukat A. Shah, MD
St. Joseph's Medical Associates, Stockton, CA 95204
Shared therapeutic areas:
Keith S. Reisinger, MD, MPH
Primary Physicians Research, Inc
Shared therapeutic areas:
Giuseppe D'Ignazio, MD
Source Unique Clinic
Shared therapeutic areas:
Lawrence P. Schwartz, MD
HCCA Clinical Research Solutions, New York, NY 10016
Shared therapeutic areas:
Terry L Poling, MD
Heartland Research Associates, LLC, Wichita, KS 67207
Shared therapeutic areas:
Michael Warren, MD
Research Across America at Oyster Point Family Health Center
Shared therapeutic areas:
Douglas W Mapel, MD
Clinical Trial Connection, Flagstaff, AZ 86001
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
Inpatient Challenge Study of rRSV A/Maryland/001/11, a Human Respiratory Syncytial Virus Challenge Strain, Administered to Healthy Adult Volunteers
Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine
Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine
Safety and Immune Response to an Investigational Dengue Type 2 Vaccine
Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study
Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals
Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults
All 9 trials loaded